Chad Cowan
Net worth: 3 M $ as of 2026-06-29
Net worth: 3 M $ as of 2026-06-29
Chad Cowan is the founder of CRISPR Therapeutics AG, founded in 2013, where the title held was Head-Research.
Dr. Cowan is also the founder of Clade Therapeutics, Inc...
Dr. Cowan is an Associate Professor at Harvard University.
Dr. Cowan is Chief Scientific Officer at Century Therapeutics, Inc. since 2024.
Dr. Cowan was Chief Scientific Officer at Sana Biotechnology, Inc. Dr. Cowan completed undergraduate studies at the University of Kansas.
Dr. Cowan earned a doctorate from The University of Texas Southwestern Medical Center.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 1,186,019 ( 0.66% ) | 3 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-09-30 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Founder | - |
| Companies | Position | End |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | - |
| CRISPR THERAPEUTICS AG | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Century Therapeutics, Inc.
Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions